Impact of Two Guided Transfusion Strategies on Blood Product Requirements in Liver Transplantation.

• Status: Recruiting
• Trial end date: 2022-10-01
• Target enrollment: 0
• Participant gender: All

Summary

It is a national multicentre clinical study, where 3 hospitals are involved: Bellvitge University Hospital, Clinic Hospital of Barcelona and Cruces Hospital of Bilbao). It is a randomized study based on the Hemoglobin value of the patient with a 1:1 ratio, parallel groups, controlled and single blind, in patients undergoing an orthotopic liver transplant, confirming previously that the participants fulfill all the inclusion criteria and none of exclusion.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Antoni Sabaté Pes

Criteria

Inclusion Criteria:

• Age > 18 years.

• Candidate to an orthotopic liver trasnplantation.

• Informed consent.

• Preoperative hemoglobine Exclusion Criteria:

• Preoperative hemoglobin> 130 g / L

• Familial amyloid polyneuropathy

• Polycystosis hepatic

• Living donor liver transplant

• Uncontrolled donor after cardiac death

• Acute / subacute liver failure

• Re-transplant (in the same hospital admission)

• Use of Anticoagulation drugs before transplantation.

• Age <18 years.

• Pregnancy and lactation.